CCDC7 Activates Interleukin-6 and Vascular Endothelial Growth Factor to Promote Proliferation via the JAK-STAT3 Pathway in Cervical Cancer Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCDC7 Activates Interleukin-6 and Vascular Endothelial Growth Factor to Promote Proliferation via the JAK-STAT3 Pathway in Cervical Cancer Cells
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 6229-6244
Publisher
Informa UK Limited
Online
2020-06-30
DOI
10.2147/ott.s244663
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- JAK/STAT proteins and their biological impact on NK cell development and function
- (2019) Alexander Vargas-Hernández et al. MOLECULAR IMMUNOLOGY
- Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
- (2019) Chin-Jui Wu et al. Cancers
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy
- (2015) Altaf A. Dar et al. JNCI-Journal of the National Cancer Institute
- The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy
- (2015) Altaf A. Dar et al. JNCI-Journal of the National Cancer Institute
- Ciliary Neurotrophic Factor Reverses Aberrant Mitochondrial Bioenergetics Through the JAK/STAT Pathway in Cultured Sensory Neurons Derived from Streptozotocin-Induced Diabetic Rodents
- (2014) Subir Roy Chowdhury et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- AAG8 promotes carcinogenesis by activating STAT3
- (2014) Bing Sun et al. CELLULAR SIGNALLING
- The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer
- (2014) Lina He et al. GYNECOLOGIC ONCOLOGY
- STAT3 Inhibitors: Finding a Home in Lymphoma and Leukemia
- (2014) J. Munoz et al. ONCOLOGIST
- IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
- (2014) Koji Taniguchi et al. SEMINARS IN IMMUNOLOGY
- Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
- (2014) Ailian Xiong et al. Cancers
- Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds
- (2013) K. Migita et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
- (2013) Xin Yao et al. PHARMACOLOGY & THERAPEUTICS
- Activation of STAT3 in Human Gastric Cancer Cells via Interleukin (IL)-6-Type Cytokine Signaling Correlates with Clinical Implications
- (2013) Zhengguang Wang et al. PLoS One
- Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?
- (2012) Andrew Jarnicki et al. Cell Division
- Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients
- (2011) Xiao-Feng Sun ONCOLOGY REPORTS
- Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model
- (2010) Yuan Wen et al. CANCER SCIENCE
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started